4-(Imidazo[1,2-a]pyridin-7-yloxy)-2-methylaniline
95%
- Product Code: 200676
CAS:
2007916-00-7
| Molecular Weight: | 239.27 g./mol | Molecular Formula: | C₁₄H₁₃N₃O |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD30471863 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | Room temperature, seal, dry |
Product Description:
Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly for targeting protein kinases involved in inflammatory diseases and cancer. Its structure supports binding to ATP sites in kinases, making it valuable in developing small-molecule therapeutics. Also explored in medicinal chemistry for optimizing lead compounds due to its favorable pharmacokinetic properties and ability to enhance target selectivity.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 100mg | 10-20 days | $297.23 |
+
-
|
| 250mg | 10-20 days | $509.81 |
+
-
|
| 1g | 10-20 days | $1,019.23 |
+
-
|
4-(Imidazo[1,2-a]pyridin-7-yloxy)-2-methylaniline
Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly for targeting protein kinases involved in inflammatory diseases and cancer. Its structure supports binding to ATP sites in kinases, making it valuable in developing small-molecule therapeutics. Also explored in medicinal chemistry for optimizing lead compounds due to its favorable pharmacokinetic properties and ability to enhance target selectivity.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
$0.00
$0.00
Total :